Cargando…

Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia

BACKGROUND: Many studies have shown that vancomycin is inferior to β-lactam antibiotics in terms of effectiveness in the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. However, limited data are available regarding the comparison of clinical outcomes between patients re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Ching-Yen, Lee, Chen-Hsiang, Chen, I-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117599/ https://www.ncbi.nlm.nih.gov/pubmed/33980167 http://dx.doi.org/10.1186/s12879-021-06111-w

Ejemplares similares

Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
por: Tsai, Ching-Yen, et al.
Publicado: (2018)

Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
por: Wong, Davie, et al.
Publicado: (2016)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Choo, Eun Ju, et al.
Publicado: (2016)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
por: Lachant, Daniel J., et al.
Publicado: (2013)

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance
por: Hamdy, Rana F, et al.
Publicado: (2017)

Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
por: Lowe, Rachel Amanda, et al.
Publicado: (2017)

Empyema Necessitans in the Setting of Methicillin-Susceptible Staphylococcus aureus Causing Pneumonia and Bacteremia
por: Bandaru, Sindhura, et al.
Publicado: (2018)

Interventions to treat methicillin-susceptible Staphylococcus aureus bacteremia: many methodological concerns
por: García-Perdomo, Herney Andrés, et al.
Publicado: (2019)

Impact of agr Functionality on the Outcome of Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Lee, Jeong Eun, et al.
Publicado: (2021)

Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis
por: Tsai, Ching-Yen, et al.
Publicado: (2018)

248. Evaluation of Continuous versus Intermittent Infusion of Nafcillin in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Williamson, Julie E, et al.
Publicado: (2023)

Long Term Molecular Epidemiology of Methicillin-Susceptible Staphylococcus aureus Bacteremia Isolates in Sweden
por: Rasmussen, Gunlög, et al.
Publicado: (2014)

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Miller, William R, et al.
Publicado: (2018)

947. Evaluating the Outcomes of Infectious Diseases Consultation on methicillin susceptible Staphylococcus aureus Bacteremia
por: Viteri, Alina, et al.
Publicado: (2022)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

Staphylococcus aureus Bacteremia, Australia
por: Collignon, Peter, et al.
Publicado: (2005)

Staphylococcus aureus Bacteremia, Europe
por: Tiemersma, Edine W., et al.
Publicado: (2005)

275. Comparison of Cefazolin versus Nafcillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia with a Deep-Seated Source
por: Mersinger, Katherine E, et al.
Publicado: (2020)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
por: Grillo, Sara, et al.
Publicado: (2023)

Timing of Initiating Glycopeptide Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: The Impact on Clinical Outcome
por: Lee, Chen-Hsiang, et al.
Publicado: (2013)

850. External Validation of the Methicillin-Resistant Staphylococcus aureus Bacteremia Score
por: Boyle, Ellen, et al.
Publicado: (2020)

Association of methicillin resistance with mortality of hospital-acquired Staphylococcus aureus bacteremia
por: Aratani, Tomonori, et al.
Publicado: (2021)

Endogenous Endopthalmitis in Disseminated Methicillin-Sensitive Staphylococcus aureus (MSSA) Bacteremia
por: Saidi, Noor Amalina, et al.
Publicado: (2023)

Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment
por: Parsons, Joshua B., et al.
Publicado: (2023)

2559. Incidence and Clinical Impact of Discordant Genotypic and Phenotypic Categorization of Methicillin Susceptibility in Staphylococcus aureus Bacteremia
por: Gulliver, Jessica, et al.
Publicado: (2018)

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
por: Honda, Hitoshi, et al.
Publicado: (2011)

Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Bigseth, Robert Strengen, et al.
Publicado: (2022)

1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?
por: Dilworth, Thomas J, et al.
Publicado: (2018)

1817. Characteristics and Outcomes in Patients with Staphylococcus lugdunensis Bacteremia Compared with Staphylococcus aureus and Staphylococcus epidermidis Bacteremia
por: Yukawa, Satomi, et al.
Publicado: (2022)

Discrimination of Methicillin-resistant Staphylococcus aureus by MALDI-TOF Mass Spectrometry with Machine Learning Techniques in Patients with Staphylococcus aureus Bacteremia
por: Kong, Po-Hsin, et al.
Publicado: (2022)

Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia
por: Gregory, Eric, et al.
Publicado: (2017)

Attributable mortality in critically ill patients with bacteremia involving methicillin susceptible (MSSA) and methicillin resistant Staphylococcus aureus (MRSA)
por: Blot, S, et al.
Publicado: (2001)

1804. Impact of Susceptibility Testing Method on Antibiotic Selection for Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia
por: Bhatt, Mahesh, et al.
Publicado: (2018)

Whole-genome sequencing to explore nosocomial transmission and virulence in neonatal methicillin-susceptible Staphylococcus aureus bacteremia
por: Slingerland, Bibi C. G. C., et al.
Publicado: (2020)

217. Combination Salvage Therapy with Cefazolin Plus Ertapenem for Refractory Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Rose Ulloa, Erlinda, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4m4vvjpp9abh9plnrpoddjvl9t